Skip to content Skip to search

Republish This Story

* Please read before republishing *

We’re happy to make this story available to republish for free under an Attribution-NonCommercial-NoDerivatives Creative Commons license as long as you follow our republishing guidelines, which require that you credit The 19th and retain our pixel. See our full guidelines for more information.

To republish, simply copy the HTML at right, which includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to The 19th. Have questions? Please email [email protected].

— The Editors

Loading...

Modal Gallery

/
Sign up for our newsletter

Menu

  • Our Mission
  • Our Team
  • Latest Stories
  • Search
  • Upcoming Events
  • Contact Us
  • Newsletter
  • Donate
  • Work With Us
  • Fellowships
    • From the Collection

      Changing Child Care

      Illustration of a woman feeding a baby a bottle
      • 1 in 4 parents report being fired for work interruptions due to child care breakdowns

        Chabeli Carrazana · February 2
      • Washington, D.C., offers financial relief to local child care workers

        Orion Rummler · September 20
      • As climate change worsens hurricane season in Louisiana, doulas are ensuring parents can safely feed their babies

        Jessica Kutz · May 5
    • From the Collection

      Next-Gen GOP

      Illustration of a woman riding an elephant
      • Mayra Flores’ victory set a record for women in Congress. It also reflects the growing visibility of Republican Latinas

        Candice Norwood · June 21
      • A banner year for Republican women

        Amanda Becker · November 11
      • Republican women could double representation in the U.S. House

        Amanda Becker · November 4
    • From the Collection

      On The Rise

      Illustration of three women marching
      • Can Cheri Beasley build a winning coalition in North Carolina?

        Candice Norwood · October 11
      • Los Angeles has never elected a woman mayor. Karen Bass hopes to change that.

        Nadra Nittle · September 8
      • Judge J. Michelle Childs is confirmed to D.C. appeals court

        Candice Norwood · July 20
    • From the Collection

      Pandemic Within a Pandemic

      Illustration of four people marching for Black Lives Matter with coronavirus as the backdrop
      • Some LGBTQ+ people worry that the COVID-19 vaccine will affect HIV medication. It won’t.

        Orion Rummler · November 23
      • Why are more men dying from COVID? It’s a complicated story of nature vs. nurture, researchers say

        Mariel Padilla · September 22
      • Few incarcerated women were released during COVID. The ones who remain have struggled.

        Candice Norwood · August 17
    • From the Collection

      Portraits of a Pandemic

      Illustration of a woman wearing a mask and holding up the coronavirus
      • For family caregivers, COVID is a mental health crisis in the making

        Shefali Luthra · October 8
      • A new database tracks COVID-19’s effects on sex and gender

        Shefali Luthra · September 15
      • Pregnant in a pandemic: The 'perfect storm for a crisis'

        Shefali Luthra · August 25
    • From the Collection

      The 19th Explains

      People walking from many articles to one article where they can get the context they need on an issue.
      • The 19th Explains: What we know about Brittney Griner’s case and what it took to get her home

        Candice Norwood, Katherine Gilyard · December 8
      • The 19th Explains: Why the Respect for Marriage Act doesn’t codify same-sex marriage rights

        Kate Sosin · December 8
      • The 19th Explains: Why baby formula is still hard to find months after the shortage

        Mariel Padilla · December 1
    • From the Collection

      The Electability Myth

      Illustration of three women speaking at podiums
      • Mayra Flores’ victory set a record for women in Congress. It also reflects the growing visibility of Republican Latinas

        Candice Norwood · June 21
      • Stepping in after tragedy: How political wives became widow lawmakers

        Mariel Padilla · May 24
      • Do term limits help women candidates? New York could be a new testing ground

        Barbara Rodriguez · January 11
    • From the Collection

      The Impact of Aging

      A number of older people walking down a path of information.
      • From ballroom dancing to bloodshed, the older AAPI community grapples with gun control

        Nadra Nittle, Mariel Padilla · January 27
      • 'I'm planning on working until the day I die': Older women voters are worried about the future

        Mariel Padilla · June 3
      • Climate change is forcing care workers to act as first responders

        Jessica Kutz · May 31
    • From the Collection

      Voting Rights

      A series of hands reaching for ballots.
      • Connecticut voters approved early voting. Here’s how their new secretary of state wants to make it happen.

        Barbara Rodriguez · February 13
      • Women lawmakers in Minnesota are in the vanguard of the democracy movement

        Barbara Rodriguez · February 3
      • Election workers believe in our system — and want everyone else to, too

        Barbara Rodriguez, Jennifer Gerson · November 8

    View all collections

  • Explore by Topic

    • 19th Polling
    • Abortion
    • Business & Economy
    • Caregiving
    • Coronavirus
    • Education
    • Election 2020
    • Election 2022
    • Election 2024
    • Environment & Climate
    • Health
    • Immigration
    • Inside The 19th
    • Justice
    • LGBTQ+
    • Military
    • Politics
    • Press Release
    • Race
    • Sports
    • Technology

    View All Topics

Home
  • Our Mission
  • Our Team
  • Latest Stories
  • Search
  • Upcoming Events
  • Contact Us
  • Newsletter
  • Donate
  • Work With Us
  • Fellowships

We’re an independent, nonprofit newsroom reporting on gender, politics and policy. Read our story.

The 19th Represents Summit

Don’t miss our biggest event of 2023!

Register Today

Become a member

The 19th thanks our sponsors. Become one.

A young woman receives the Johnson & Johnson vaccine from.a pediatric nurse practitioner.
Rishell of Cleveland Park, receives the Johnson & Johnson COVID-19 vaccine from Heidi Johnson, pediatric nurse practitioner, at Grubb's Pharmacy on Capitol Hill on Monday, April 12, 2021. (Photo By Tom Williams/CQ-Roll Call, Inc via Getty Images)

Coronavirus

The U.S. is recommending pausing Johnson & Johnson’s COVID vaccine. Women wonder what’s next.

Touted as a tool for equity, the vaccine is on hold after six women developed blood clots soon after getting a shot. The complications are still exceedingly rare.

By

Shefali Luthra, Barbara Rodriguez

Published

2021-04-13 07:21
7:21
April 13, 2021
am

Updated

2021-04-13 11:33:49.000000
America/Chicago

Share

  • Twitter
  • Facebook
  • Email

Jessi Healey had been looking forward to receiving her Johnson & Johnson one-dose coronavirus vaccine on Tuesday. She scheduled the shot last week, on the first day that the 37-year-old was eligible to get vaccinated in North Carolina.

On the same day Healey was set to get her vaccination, the federal government recommended a pause on Johnson & Johnson vaccines after six women developed blood clots and low blood platelet levels within two weeks of taking the shot — advice vaccine providers are already taking up. 

The condition is exceedingly rare. More than 6.8 million people have gotten the Johnson & Johnson vaccine so far, making the chance of having developed a clot less than 1 in a million. Every case occurred in a woman between ages 18 and 48, sometimes between 6 and 13 days after vaccination. 

The 19th thanks our sponsors. Become one.

Healey, a self-employed social media manager who lives in a suburb of Charlotte, woke up to the news and felt frustrated. She had spent hours online looking for a vaccine shot, and as appointments were snatched up in real time as she tried to book, she finally secured a Johnson & Johnson shot. Just a few hours before her Tuesday afternoon appointment, staff at the pharmacy where Healey was scheduled to visit called her to cancel.

“My frustration is not with the precaution, or even the hassle,” she said. “It’s more just that I want to get the vaccine. A vaccine.”

Healey is now back to looking. Staff at the pharmacy said they didn’t have any appointments available, so she’s checking her options online. Healy is the only adult in her household who has yet to get a shot, and it’s weighing on her as she tries to make plans with her family.

Stories by experienced reporters you can trust and relate to.

Delivered directly to your inbox every weekday.

Please check your email to confirm your subscription!

Submitting…

Uh-oh! Something went wrong. Please try again later.

A top advisory committee to the Centers for Disease Control will meet Wednesday to discuss the data on the blood clots. The pause is expected to last only a few days, Food and Drug Commissioner Janet Woodcock told reporters Tuesday. The Johnson & Johnson vaccines make up a fraction of the 190 million COVID-19 vaccine doses so far administered in the United States.

The pause is recommended out of an “abundance of caution,” government officials stressed. 

“This is important, in part, to ensure that the health care provider community is aware of the potential for these adverse events and can plan for proper recognition and management due to the unique treatment required with this type of blood clot,” Dr. Anne Schuchat, principal deputy director of the Centers for Disease Control and Prevention and Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in a statement. 

Government officials said they are communicating with local vaccine providers to make sure people who had appointments for Johnson & Johnson vaccines get rescheduled imminently with other vaccines.

“This may be a bit bumpy,” Schuchat said in a press conference. “We want to make sure people who had been scheduled for vaccination are able to get that.”

The issue involves cerebral venous sinus thrombosis, a blood clot that is very rare and requires different treatment from other kinds of blood clots. It appears similar to a blood clot seen in rare cases with the AstraZeneca vaccine, which is being used in many other countries but not yet in the United States. Some countries have temporarily paused the use of the AstraZeneca shot, but public health experts have stressed that the rarity of developing a blood clot does not outweigh the immense benefit of getting a vaccine.

Some researchers worry that pausing the Johnson & Johnson shot could make people more hesitant about taking a coronavirus vaccine — and not just Johnson & Johnson’s. 

“The problem is people are going to look at this and not dig into any of the other stuff. They’re going to be like, ‘People don’t know what they’re doing,’ and not get the vaccine,” said Rupali Limaye, an associate scientist at Johns Hopkins University, who studies vaccine hesitancy. “I think people will take this experience and apply it to anything that comes on the market.”

Women interviewed by The 19th expressed concern — some about their own health, and others for the wider implications the news could have on general vaccine uptake and accessibility.

Megan Parcell, a mother of two in Indianapolis, got the Johnson & Johnson shot last week at a local CVS pharmacy. The news on Tuesday rattled the account executive. Although the 35-year-old hasn’t experienced any serious symptoms related to her shot, she said her family has a history of blood clots. She would have actively sought another vaccine had she known about the potential risk. She is considering reaching out to her doctor as a precaution.

“I keep telling myself like, ‘OK. It’s six individuals as of right now, like six out of the millions that have gotten it.’ So I’m trying to figure out how I’m going to cope with my anxiety for the next week until I get out of that 13-day window.”   

Though all six cases have appeared in women, the sample is too small to determine whether certain groups of people were at greater risk for blood clots, government officials said. More blood clotting cases may be identified in coming days, though Marks said he hopes the number is small. 

Oral hormonal contraception can also elevate the risk for blood clotting by between .3 percent and 1 percent over a decade. But so far, though all women who developed clots were of reproductive age, “it’s not clear that there’s any association with oral contraceptive pill birth control,” Marks said. 

Unlike the Pfizer and Moderna vaccines, the Johnson & Johnson shot was tested in areas that included the more transmissible coronavirus variant first seen in South Africa. Slowing down use of that vaccine — or eroding vaccine confidence — could be particularly damaging, Limaye worried. 

Because the vaccine only requires one dose it has also been touted as particularly effective in reaching people who might not have the time and flexibility to easily schedule two shots. Unlike the Pfizer and Moderna vaccines, it does not require freezer storage, which had also made it potentially more viable in rural areas, or for use in mobile clinics.

Jangela Shumskas got her Johnson & Johnson shot last Wednesday at a community center in Washington, D.C. The 44-year-old consultant, who posted a video of herself getting the shot on social media, said she is not panicking about the news because of the statistical rarity of the cases. She said she’ll monitor for any additional cases, but she’s more concerned about the implications for others. She specifically scheduled a Johnson & Johnson shot to show others it is a safe option.

“I feel kind of remorseful that one of the most promising vaccine candidates that we had available to kind of get to lower-income communities — and to households that are less able to make it to two appointments and to individuals and households that need immunogenicity sooner rather than later — this is a big blow,” she said. 

Shumskas added that she is concerned about the ramifications of the pause on women who had been eligible for the Johnson & Johnson shot.

“We’re the group that has been hit the hardest between job losses and child care and scheduling. The ability to not have to go in for two vaccinations was huge,” she said. “And that’s been taken off the table for women, and this is just another thing that shows that women are getting hit yet again.” 

Share

  • Twitter
  • Facebook
  • Email

The 19th Represents Summit

Don’t miss our biggest event of 2023!

Register Today

Become a member

Up Next

A silhouette of a pregnant woman.

Health

Illinois will extend insurance for postpartum people. It could fight pregnancy-related deaths.

The state is the first to extend postpartum Medicaid coverage, so people keep insurance for a year after giving birth. Others are likely to follow.

Read the Story

The 19th
The 19th is a 501(c)(3) tax-exempt organization. Our stories are free to republish in accordance with these guidelines.

  • Donate
  • Newsletter
  • Events
  • Search
  • Jobs
  • Fellowships
  • Contact Us
  • About Us
  • Community Guidelines
  • Membership
  • Membership FAQ
  • Major Gifts
  • Sponsorship
  • Privacy
  • Twitter
  • Facebook
  • Instagram